2017-05-30 18:05:24 UTC

2017 Freston Preview: Synthesis and Release of Extracellular Vesicles

May 30, 2017

Learn about session two of the 2017 Freston conference taking place in St. Paul, MN this September.

We're back with another preview of the 2017 James W. Freston conference, which delves deeper into vesicle biogenesis and secretion — revealing its relevance to GI diseases and clinical applications.

This week we’ll provide insight on session two. We've already previewed session one of the conference, which takes place Sept. 9 and 10, 2017, in St. Paul, MN. See highlights from session two below.

Discovery: Biogenesis and Secretion (Cont’d)
Session two continues with examining the synthesis and release of extracellular vesicles (EVs). Prominent investigators Robert J. Coffey, MD, Harmeet Malhi, MBBS, and Nicholas F. LaRusso, MD, AGAF, will lead attendees in:

  • Discussing the role of carrier-mediated ceramide transport in EV biogenesis.
  • Examining the mechanism by which STARD11 promotes EV biogenesis.
  • Discussing the biogenesis of palmitate-stimulated lipotoxic EVs to determine if these are exosomes or microparticles.
  • Better understanding how and why epithelial cells release EVs in a polar fashion and the consequences for target cells.

Stay tuned to AGA eDigest and the AGA website for details on sessions three and four. To register and view the program in its entirety, visit the conference website. Early registration ends Wednesday, June 14.

Funded by the Takeda Endowment in support of the James W. Freston Single Topic Conference.